Establishing a pipeline of innovative medicines for the treatment of
Contact us directly for more information on our business development strategy.
AUM will embed trial digitalization from day one of clinical development
AUM’s precision medicine approach aims to reduce clinical trial times and patient numbers
Fewer than 20% of newly approved medicines in 2017 were available in emerging markets, specifically Asia1
1 IQVIA Oncology trend report 2018